OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis $0.90 +0.02 (+2.48%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest About Cresco Labs Stock (OTCMKTS:CRLBF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cresco Labs alerts:Sign Up Key Stats Today's Range$0.85▼$0.9450-Day Range$0.88▼$1.7152-Week Range$0.85▼$2.65Volume1.60 million shsAverage Volume766,430 shsMarket Capitalization$439.33 millionP/E RatioN/ADividend YieldN/APrice Target$2.50Consensus RatingModerate Buy Company OverviewCresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More… Cresco Labs Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks53rd Percentile Overall ScoreCRLBF MarketRank™: Cresco Labs scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingCresco Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 3 research reports in the past 90 days.Read more about Cresco Labs' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cresco Labs are expected to grow in the coming year, from ($0.20) to ($0.05) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -4.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -4.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.16% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 5.68%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.16% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 5.68%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News SentimentN/A News SentimentCresco Labs has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cresco Labs this week, compared to 2 articles on an average week.Search Interest2 people have searched for CRLBF on MarketBeat in the last 30 days. MarketBeat FollowsOnly 8 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.05% of the stock of Cresco Labs is held by institutions.Read more about Cresco Labs' insider trading history. Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address CRLBF Stock News HeadlinesCresco Labs Inc. (OTCMKTS:CRLBF) Receives Average Recommendation of "Moderate Buy" from BrokeragesDecember 13, 2024 | americanbankingnews.comCresco Labs FY2025 EPS Estimate Lifted by Atb Cap MarketsDecember 12, 2024 | americanbankingnews.comCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.December 22, 2024 | ProsperityPub (Ad)Cresco Labs (OTCMKTS:CRLBF) Cut to Hold at Atb Cap MarketsDecember 12, 2024 | americanbankingnews.comCan Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election ReckoningNovember 18, 2024 | benzinga.comCresco Labs downgraded to Market Perform from Speculative Buy at CormarkNovember 13, 2024 | markets.businessinsider.comCresco Labs Reports Record Cash Flow GrowthNovember 10, 2024 | markets.businessinsider.comCresco Labs Inc. (CRLBF) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comSee More Headlines CRLBF Stock Analysis - Frequently Asked Questions How have CRLBF shares performed this year? Cresco Labs' stock was trading at $1.3558 at the beginning of 2024. Since then, CRLBF stock has decreased by 33.6% and is now trading at $0.90. View the best growth stocks for 2024 here. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) announced its quarterly earnings data on Tuesday, March, 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $199.58 million for the quarter, compared to the consensus estimate of $204.47 million. Cresco Labs had a negative trailing twelve-month return on equity of 16.52% and a negative net margin of 9.15%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings3/21/2023Today12/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees2,760Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$3.00 Low Stock Price Target$2.00 Potential Upside/Downside+177.8%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-175,520,000.00 Net Margins-9.15% Pretax Margin-0.12% Return on Equity-16.52% Return on Assets-4.81% Debt Debt-to-Equity Ratio1.80 Current Ratio1.97 Quick Ratio1.39 Sales & Book Value Annual Sales$770.89 million Price / Sales0.57 Cash Flow$0.05 per share Price / Cash Flow19.66 Book Value$1.24 per share Price / Book0.73Miscellaneous Outstanding Shares488,140,000Free FloatN/AMarket Cap$439.33 million OptionableNot Optionable Beta1.73 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (OTCMKTS:CRLBF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cresco Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.